BR0314804A - Forma de dosagem de liberação modificada - Google Patents

Forma de dosagem de liberação modificada

Info

Publication number
BR0314804A
BR0314804A BR0314804-1A BR0314804A BR0314804A BR 0314804 A BR0314804 A BR 0314804A BR 0314804 A BR0314804 A BR 0314804A BR 0314804 A BR0314804 A BR 0314804A
Authority
BR
Brazil
Prior art keywords
dosage form
modified release
release dosage
active ingredient
opening
Prior art date
Application number
BR0314804-1A
Other languages
English (en)
Inventor
Harry S Swoden
Gerard P Mcnally
David Wynn
Oliver Anderson
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031117 external-priority patent/WO2003026629A2/en
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Priority claimed from PCT/US2003/008894 external-priority patent/WO2004028508A1/en
Publication of BR0314804A publication Critical patent/BR0314804A/pt

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMA DE DOSAGEM DE LIBERAçãO MODIFICADA". é fornecida uma forma de dosagem de liberação modificada compreendendo pelo menos um ingrediente ativo e pelo menos dois núcleos circundados por uma casca. A casca compreende pelo menos uma abertura e fornece liberação modificada de ingrediente ativo no contato da forma de dosagem com um meio líquido. Pelo menos um dos núcleos é distal da abertura. Em uma modalidade preferida, a forma de dosagem tem um perfil de liberação pulsátil.
BR0314804-1A 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada BR0314804A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2003/008894 WO2004028508A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms with two cores and an opening

Publications (1)

Publication Number Publication Date
BR0314804A true BR0314804A (pt) 2005-08-02

Family

ID=34271652

Family Applications (5)

Application Number Title Priority Date Filing Date
BR0314547-6A BR0314547A (pt) 2002-09-28 2003-03-21 Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo
BR0314781-9A BR0314781A (pt) 2002-09-28 2003-03-21 Composição de polìmero e formas de dosagem compreendendo a mesma
BR0314777-0A BR0314777A (pt) 2002-09-28 2003-03-21 Formas de dosagem de liberação modificada
BR0314787-8A BR0314787A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada
BR0314804-1A BR0314804A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada

Family Applications Before (4)

Application Number Title Priority Date Filing Date
BR0314547-6A BR0314547A (pt) 2002-09-28 2003-03-21 Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo
BR0314781-9A BR0314781A (pt) 2002-09-28 2003-03-21 Composição de polìmero e formas de dosagem compreendendo a mesma
BR0314777-0A BR0314777A (pt) 2002-09-28 2003-03-21 Formas de dosagem de liberação modificada
BR0314787-8A BR0314787A (pt) 2002-09-28 2003-03-21 Forma de dosagem de liberação modificada

Country Status (8)

Country Link
JP (3) JP2006517183A (pt)
CN (3) CN1700907A (pt)
AT (1) ATE444739T1 (pt)
AU (4) AU2003220472A1 (pt)
BR (5) BR0314547A (pt)
CA (3) CA2500312A1 (pt)
DE (2) DE60335270D1 (pt)
MX (1) MXPA05003283A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
EP2299986A1 (en) * 2008-06-19 2011-03-30 University Of The Witwatersrand, Johannesburg A chronotherapeutic pharmaceutical dosage form
JPWO2011118454A1 (ja) * 2010-03-23 2013-07-04 リンテック株式会社 固形製剤
WO2013009701A2 (en) * 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
EP2811985B1 (en) * 2012-02-07 2018-10-17 Johnson & Johnson Consumer Inc. Rapidly disintegrating coated tablets
US9693962B2 (en) * 2012-06-05 2017-07-04 Takeda Pharmaceutical Limited Dry-coated tablet
MX2017003556A (es) * 2014-09-19 2017-07-14 Procter & Gamble Formas de dosificacion de fenilefrina de liberacion pulsada.
AU2017445093B2 (en) 2017-12-29 2024-09-19 Exentis Knowledge Gmbh Drug delivery system
CA3226223A1 (en) * 2021-07-30 2023-02-02 Jacob Pade Ramsoe Jacobsen 5-hydroxytryptophan gastroretentive dosage forms
CN115295864B (zh) * 2021-11-09 2023-08-11 深圳市德方创域新能源科技有限公司 正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2142982A1 (en) * 1992-09-30 1994-04-14 Julian Belknap Lo Articles for sustained release of medications
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
WO2001078681A1 (fr) * 2000-04-17 2001-10-25 Yamanouchi Pharmaceutical Co., Ltd. Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
JP2004518709A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤

Also Published As

Publication number Publication date
JP2006517183A (ja) 2006-07-20
CN1684671A (zh) 2005-10-19
CA2500312A1 (en) 2004-04-08
AU2003218359A1 (en) 2004-04-19
BR0314781A (pt) 2005-07-26
BR0314777A (pt) 2005-07-26
BR0314547A (pt) 2005-08-09
JP2006517182A (ja) 2006-07-20
CN1700908A (zh) 2005-11-23
BR0314787A (pt) 2005-07-26
AU2003220472A1 (en) 2004-04-19
MXPA05003283A (es) 2005-11-23
CA2500313C (en) 2011-06-07
AU2003220466A1 (en) 2004-04-19
DE60335270D1 (de) 2011-01-20
CA2500313A1 (en) 2004-04-08
DE60329614D1 (de) 2009-11-19
CN1700907A (zh) 2005-11-23
JP2006517514A (ja) 2006-07-27
ATE444739T1 (de) 2009-10-15
CA2500311A1 (en) 2004-04-08
AU2003225944A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
BR0212946A (pt) Formas de dosagens de liberação modificada
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
BR0314804A (pt) Forma de dosagem de liberação modificada
ES2111547T3 (es) Comprimido de liberacion prolongada.
AU2002239830A1 (en) Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
BRPI0414215A (pt) tienopirazóis
EA200200207A1 (ru) Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
BR9803233A (pt) Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares.
EP1284265A4 (en) BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF
ATE360428T1 (de) Analgetisches arzneimittel
IL160474A0 (en) Combination products of 1,4-benzothiepine 1,1-dioxide derivatives with other active ingredients and the use thereof
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
BR0213536A (pt) Formulações de xarope de ribavirina
BR0314056A (pt) Métodos de medição da taxa de dissolução de um analisado em uma composição lìquida não-aquosa
HUP0104652A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása öregkori szervi rendellenességek és öregkori betegségek megakadályozására és az élet meghosszabbítására alkalmas gyógyszerkészítmények előállítására
BR0108405A (pt) Agente de ativação de célula
SE0001916D0 (sv) Novel formulation
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
SE0001071D0 (sv) Method of inhibiting the expression of inflammatory cytokines and chemokines
AR030647A1 (es) Composicion farmaceutica con actividad de agua especifica
SE9802538D0 (sv) New pharmaceutically active compounds
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
ATE259778T1 (de) Nicht-hygroskopische salze aktiver inhaltsstoffe, die therapeutische und/oder ernährungsphysiologische eigenschaften haben und oral verabreichbare zusammensetzungen, die diese enthalten

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]